Unlike the U.S. market, the U.K. market has never been very fond of technology stocks, including biotechnology companies. Their valuations—and the levels of interest they… Read More »Biotech’s Unknown Star Is Set To Take Off
Just when you thought it was safe to go outside, monkeypox pops up. This might not be bad news for the market, as the world… Read More »Moneypox Outbreak Puts Focus On These Two Biotechs
While there may be little difference between the COVID-19 vaccines developed by BioNTech and Moderna, there are some significant differences between the two companies –… Read More »Do Investors Have A Better Shot With BioNTech Or Moderna?
Of the eight globally listed exchange traded products that track the Nasdaq Biotechnology Index (the gold standard of biotech indexes), this newly minted ETF is… Read More »This Biotech ETF Is New, Practical & Cost-Effective
Radiation, surgery, chemotherapy…and electric fields? This oncology company has developed a fourth paradigm for treating cancer – and has multiple data readouts this year that… Read More »A Cancer Play With A New Treatment Paradigm – And Multiple Data Readouts This Year
As has been on full display in recent weeks, developing an effective vaccine is one thing. Rolling it out efficiently is another. As one tech/industrial… Read More »A Way To Play This Vaccine Rollout Partnership